SUN Pharma has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine based on a tailored recombinant virus-like-particle (VLP) tetravalent prototype.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 16
